Save Up To 70% with generic medications and up to 40% with brand name drugs. Get FREE WorldWide shipping on $149 or more...
Epilepsy » UCB Receives CHMP Positive Opinion On...
Home » News » UCB Receives CHMP Positive Opinion On...
UCB Receives CHMP Positive Opinion On Keppra(R) For Infants And Young Children With Partial-onset Epilepsy
UCB announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending that the European Commission grant marketing authorisation for Keppra® as adjunctive treatment of partial-onset seizures in infants and young children aged one month to under four years.
Read full article @ MedicalNewsToday
Read Also Other "Epilepsy" News
-
'Catastrophic Epilepsy' Caused By Single Gene Mutation
Catastrophic epilepsy - characterized by severe muscle spasms, persistent...
